Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

A recent study found that up to 40% of trials might be untrustworthy due to flaws in design, improper data collection, and ...

Blue Arbor Technologies today announced a partnership with Ottobock, anchored by a $5 million investment to advance neuromuscular tech.

The successful commercialization of innovative medical technologies remains a cornerstone of advancing healthcare delivery and patient outcomes. The journey from a novel concept to a market-ready ...